LifeMD raises $21.4M from common, $32.9M from preferred stock offerings

LifeMD, Inc.

3.83M common shares sold at $6.00/share; net proceeds ~$21.4M; $5M used to repay debt.
1.4M shares of 8.875% Series A Cumulative Perpetual Preferred at $25.00/share; net ~$32.9M.
Series A Preferred pays 8.875% cumulative quarterly dividends on $25.00 liquidation preference.
Proceeds to repay debt, fund dividend account, and for patient acquisition and acquisitions.
Both offerings closed Oct 4, 2021; underwriters' option exercised in full for common.

item 1.01 item 3.03 item 5.03 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.